Top Markets
Coin of the day
Immunotech Biopharm Ltd Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

6978
Clasificación en acciones #27877
Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in... Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in cellular immunotherapy. Its primary activities involve the investigation, development, and market introduction of T cell-based immunotherapy solutions for various cancers within the People's Republic of China. The company's flagship product, EAL, is a multi-target cellular immunotherapy currently undergoing Phase II clinical trials for the purpose of preventing liver cancer recurrence after surgery. Furthermore, Immunotech Biopharm is conducting both preclinical and clinical research on EAL for its potential use in treating lung cancer, glioma, gastric cancer, and colorectal cancer. Other pipeline assets include the 6B11-OCIK injection, which is in Phase I trials for ovarian cancer; the CAR-T-19 injection product, targeting B-cell acute lymphoblastic leukaemia; and a range of TCR-T cell products designed for solid tumor treatment. Established in 2006, the company's main office is located in Beijing, China.
Precio por acción
$0.04861197
Capitalización bursátil
$30.02M
Cambio (1 día)
0.00%
Cambio (1 año)
-91.39%
País
CN
Comercio Immunotech Biopharm Ltd (6978)

Categoría

Historial de desdoblamientos de acciones de Immunotech Biopharm Ltd (6978)
La acción Immunotech Biopharm Ltd (símbolo: 6978) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 20, 2026.
Una acción 6978 comprada antes de Aug 20, 2026 equivaldría hoy a 0 acciones 6978.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH